Introduction

We are a bioinformatics research group in the Department of Biomedical Informatics at Harvard Medical School. We are part of the Ludwig Center at Harvard, Division of Genetics at Brigham and Women’s Hospital and Harvard-MIT Division of Health, Science, & Technology.

Our main aim is to understand the genetic and epigenetic mechanisms that underlie disease processes through computational and statistical analysis of genomic data. We are particularly interested in mutational processes in normal and cancer cells and their impact in gene regulation.

Collaborative science

We have the privilege of collaborating with a number of superb experimental laboratories at Harvard Medical School and its affiliated hospitals, as well as around the world. Our recent and current collaborators include Connie Cepko, George Daley, Steve Elledge, Konrad Hochedlinger, Mark Johnson, Mitzi Kuroda, Jordan Kreidberg, Bob Kingston, William Pu, Charlie Roberts, Chris Walsh, and Fred Winston.

Here are some consortium projects in which we are involved:

  • SMaHT (Somatic Mosaicism across Human Tissues), starting in 2023 - Do mutations accumulate in non-cancer cells? Where and how? Can those mutations lead to cancer or other diseases?
  • 4D Nucleome - What are the principles underlying three-dimensional organization of the human genome? What is the role of the nuclear architecture in gene regulation? As the Data Coordination and Analysis Center for this major NIH initiative, we will collect, process, and display all data generated in the consortium and to perform integrative analysis. Main collaborators: Peter Kharchenko (HMS), Leonid Mirny (MIT), Nils Gehlenborg (HMS), Hanspeter Pfister (Harvard) and Ting Wang (WashU).
  • Brain Somatic Mosaicism Network - The aim of this network is to characterize the spectrum of somatic variation in human brain samples and its role in psychiatric disorders. We are studying somatic mosaicism in autism with Chris Walsh (Boston Children’s) and schizophrenia with Andy Chess (Mt. Sinai).
  • Ludwig Center - This center brings together investigators from across Harvard to develop strategies to overcome the problem of therapy resistence in cancer.
  • International Cancer Genome Consortium - This is an effort by the international cancer genomics community to jointly analyze ~2,500 cancer genomes.

Latest News

Oct 2026:   Park Lab Hiking Trip 2026

Park lab went on its annual hiking trip over the long weekend and witnessed some beautiful fall views.

Oct 2026:   Welcome Liz and Zofia!

Welcome Liz and Zofia! Park lab recently welcomed two new Associate Compuational Biologists, Liz Imhoff and Zofia Dudek. Liz completed a master’s degree in Computational Biology and Quantitative Genetics from Harvard T.H. Chan in 2025 after which she worked in the Leshchiner Lab at Boston University, analyzing cancer genomics data from individuals with CLL. Zofia completed an MS in Bioengineering and Biomedical Data Science at Stanford.

Sep 2026:   Julia's Farewell

After nearly four years in the Park Lab, Julia returns to Germany to start a new adventure. Park lab will miss her hardwork, excitement, and ability to bring the whole team together. Farewell Julia!

Aug 2026:   Cassie's Farewell

As the website updater today I am posting about my own farewell! Park lab gathered together to send me off after four years with the team. It is a very bittersweet feeling and I already miss the team so much. Wishing all of Park lab the best of luck!

Aug 2026:   Welcome Daniel!

Park lab is excited to welcome BIG PhD student Daniel Feng to the team! Daniel graduated from the University of Illinois, Urbana-Champaign in 2025 with a Bachelor’s degree in Computer Science. As an undergraduate, he researched computational cancer phylogenetics, network clustering, and the probabilistic modelling of errors in microsatellite duplex sequencing. In the Park Lab, Daniel is developing algorithmic methods for analyzing and compressing different types of next generation sequencing data! Welcome Daniel!